We examined USP25 expression in postmortem brain samples from individuals with AD and age-matched controls and found that USP25 protein levels remained unchanged in patients with sporadic AD compared with controls without AD; here, the synaptic marker synaptophysin was used as a control (Figure 8, A and B). Here, USP25 is linked to Alzheimer disease.